Sun Pharma’s Utreglutide shows weight loss, gluco-metabolic and lipid-lowering efficacy EP News Bureau Jun 24, 2024 GL0034 (Utreglutide) administered once weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters…
Sun Pharma announces pre-clinical data on GL0034, an experimental NCE to treat Type 2 diabetes and… EP News Bureau Jun 25, 2020 The experimental New Chemical Entity (NCE), GL0034 is a long-acting GLP-1R (Glucagon-Like Peptide-1 Receptor) agonist
